PIWA
CVS icon

Prevail Innovative Wealth Advisors’s CVS Health CVS Stock Holding History

Prevail Innovative Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,144
Closed -$2M – 191
2025
Q4 		$2M Buy
25,144
+1,533
+6% +$121K 0.36% 106
2025
Q3 		$1.78M Buy
23,611
+11,465
+94% +$786K 0.35% 104
2025
Q2 		$838K Buy
+12,146
New +$796K 0.19% 146

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prevail Innovative Wealth Advisors's CVS Position: Q1 2026 in Review

Prevail Innovative Wealth Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 25,144 shares — an estimated $2M sold.

Prevail Innovative Wealth Advisors first reported a position in CVS in Q2 2025 and held it in 3 quarters. The position peaked at $2M in Q4 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Prevail Innovative Wealth Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Prevail Innovative Wealth Advisors sold 25,144 CVS Health shares in Q1 2026, an estimated $2M.
  • Prevail Innovative Wealth Advisors first reported a position in CVS Health in Q2 2025 and held it in 3 quarters.
  • Prevail Innovative Wealth Advisors's CVS Health position peaked at $2M in Q4 2025.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.